Symbols

Symbols

Aime

Products

News

Markets

Watchlist

Brokers

News/

Stock/

CALC

CALC News

Newswire

07:23

CalciMedica Q3 results: AKI trial ongoing, FDA talks positive, cash to fund ops till H2 2026.

07:03

CalciMedica's CM5480 shows promise in PAH treatment, cardiac benefits support AKI therapy.

07:03

CalciMedica reports Q3 results, cash to fund operations to 2H 2026.

07:03

CalciMedica's Auxora treatment reduces inflammation in AKI rat model.

07:04

CalciMedica Collaborates with Telperian on AI-Driven Clinical Trial Analysis

View More

About CALC

Charts

--

Sector--

Established Date--

Listing Date--

Exchange--

Full-time Employees--

Fiscal Year Ends--

Website

Security Type--

Office address

Business

Introduction

View More